| 1: |
Strategic Marketing & Distribution Alliance for 'Accu Check - Go'.
Roche Diagnostics and Mankind Pharma recently announced an exclusive marketing and distribution agreement wherein the latter will undertake marketing and distribution activities for 'Accu-Chek Go', a newly launched blood glucose monitoring device by Roche Diagnostics, in India.
With Mankind's strong distribution and marketing force, Accu-Chek Go will be available across 500 cities in India. The purpose of this co-operation is to raise awareness for diabetes and to spread the message of self-monitoring in Indian homes. Both parties have the declared goal to enable people with diabetes leading a life as normal as possible despite their condition and to provide efficient and effective diabetes management solutions to them in metros, mini metros and rural towns in India.
Said Sanjeev Johar, Asia Pacific Regional Head, Diabetes Care, " This arrangement provides India's vast urban and suburban areas access to our best-in-class products and services, and aligns perfectly with our philosophy of meeting 'unmet needs' in our chosen markets."
Said RC Juneja, Managing Director, Mankind Pharma, "The synergy between Mankind and Roche to provide best solutions in diabetes management is ideal for both parties."
"Accu-Chek Go" is a new, fast, low blood volume system that offers advanced and accurate testing with its hygienic test strip ejection and customisable safety settings. The small, sleek Accu-Chek Go gives competent support to people with diabetes: the meter features an adjustable personalised blood glucose target range and its 'alarm clock' function has four individually programmable alarm times. In addition, the Accu-Chek Go meter offers even more features that make monitoring blood glucose levels convenient and reliable: the test strip's capillary fill function means the application of blood is fast, easy and hygienic; reliable results are ready in about five seconds; and the strip ejector allows to dispose of used test strips without handling them.
|
|
| 2: |
Mankind forays into OTC segment; targets Rs 1,100 cr top-line.
New Delhi, March 29: Drug firm Mankind Pharma on Thursday said it will invest Rs 15 crore to foray into the domestic OTC drug market, as it targets a two-fold jump in its top-line to cross the Rs 1,000 crore revenue mark by 2009-10.
"We would close the current fiscal at Rs 550 crore and are targeting to touch the Rs 1,100 crore mark by 2009-10. The new OTC division is expected to contribute Rs 125 crore to the overall revenues by then," R C Juneja told reporters here.
He said the major portion of the earmarked Rs 15 crore in the OTC division would go towards strengthening dealership network and increasing brand presence across the country.
The company had test launched its OTC products in parts of Uttar Pradesh in December 2006 and has clocked sales of Rs 1.25 crore in the first three months in the State, he said.
Mankind is looking at a pan-India presence in the Rs 20,000 crore domestic OTC market by the end of this year and would be present through more than 2,000 retailers across the country.
The company is targeting revenues of Rs 30 crore from the first full year of operations of the OTC division.
The OTC division would sell products including shampoos, soaps, energy drinks, calorie free sweeteners, sanitary napkins, medicated dressings, condoms and diapers.
The company expects exports to contribute 7-8 per cent to its overall revenues by 2010.
Bureau Report ZEE NEWS.COM
|
|